Evidence map›Paper›PMID 36636604›Full record

ArticleEvidence-based complementary and alternative medicine : eCAM2023

Integrated Network Pharmacology and Gut Microbiota Analysis to Explore the Mechanism of Sijunzi Decoction Involved in Alleviating Airway Inflammation in a Mouse Model of Asthma.

Wenqing Jia, Chengling Xu, Tong Zhao, Qiuyang Fan, Bo Qiao, Yueying Wu, Jiali Yuan, Jing Chen

Open access · hybridAbstract read
In one paragraph

Article in Evidence-based complementary and alternative medicine : eCAM, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
2.3field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 13 citations in OpenAlex.

  1. Mechanisms ofBiology · 2025
    Article
  2. Article
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 1 country.

Wenqing JiaSchool of Basic Medical Science, Yunnan University of Chinese Medicine, Kunming, Yunnan, China.ORCID https://orcid.org/0000-0002-6974-3668
Chengling XuSchool of Basic Medical Science, Yunnan University of Chinese Medicine, Kunming, Yunnan, China.ORCID https://orcid.org/0000-0001-8854-9281
Tong ZhaoSchool of Basic Medical Science, Yunnan University of Chinese Medicine, Kunming, Yunnan, China.ORCID https://orcid.org/0000-0002-5459-839X
Qiuyang FanSchool of Basic Medical Science, Yunnan University of Chinese Medicine, Kunming, Yunnan, China.ORCID https://orcid.org/0000-0002-2967-2420
Bo QiaoSchool of Chinese Medical Science, Hunan University of Chinese Medicine, Changsha, Hunan, China.
Yueying WuCollege of First Clinical Medical Science, Yunnan University of Chinese Medicine, Kunming, Yunnan, China.ORCID https://orcid.org/0000-0002-2608-6338
Jiali YuanYunnan Key Laboratory of Molecular Biology of Traditional Chinese Medicine, Kunming, Yunnan, China.ORCID https://orcid.org/0000-0003-4741-1299
Jing ChenSchool of Basic Medical Science, Yunnan University of Chinese Medicine, Kunming, Yunnan, China.ORCID https://orcid.org/0000-0002-1088-0019
Yunnan University · CNHunan University of Traditional Chinese Medicine · CNYunnan University of Traditional Chinese Medicine · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Asthma is a chronic inflammatory disease of the airways with recurrent attacks, which seriously affects the patients' quality of life and even threatens their lives. The disease can even threaten the lives of patients. Sijunzi decoction (SJZD), a classical Chinese medicine formula with a long history of administration, is a basic formula used for the treatment of asthma and demonstrates remarkable efficacy. However, the underlying mechanism has not been elucidated. Materials and Methods: We aimed to integrate network pharmacology and intestinal flora sequencing analysis to study the mechanism of SJZD in the treatment of allergic asthmatic mice. The active compounds of SJZD and their asthma-related targets were predicted by various databases. We performed Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) analyses to identify potentially relevant pathways for target genes. Furthermore, the active compound-target and target-signaling pathway network maps were constructed by using Cytoscape 3.8.2. These results were combined with those of the intestinal flora sequencing analysis to study the influence of SJZD on airway inflammation in allergic asthmatic mice. Result: We obtained 137 active compounds from SJZD and associated them with 1445 asthma-related targets acquired from the databases. A total of 109 common targets were identified. We visualized active compound-target and target-signaling pathway network maps. The pathological analysis and inflammation score results suggested that SJZD could alleviate airway inflammation in asthmatic mice. Sequencing analysis of intestinal flora showed that SJZD could increase the relevant abundance of beneficial bacterial genus and maintain the balance of the intestinal flora. The core toll-like receptor (TLR) signaling pathway was identified based on network pharmacology analysis, and the important role TLRs play in intestinal flora and organismal immunity was also recognized. The analysis of the correlation between environmental factors and intestinal flora revealed that beneficial bacterial genera were negatively correlated with TLR2 and positively correlated with the TLR7 expression. Furthermore, they were positively correlated with IFN- Conclusion: SJZD alleviated the airway inflammation state in asthmatic mice. The findings suggest that increasing the relevant abundance of beneficial intestinal bacteria in mice with asthma, regulating intestinal flora, interfering with the level of TLR2 and TLR7 expression to adjust the secretion of inflammatory factors, and alleviating asthmatic airway inflammation may be the possible mechanism involved in the treatment of asthma by SJZD, providing a basis for further studies on SJZD.

Identifiers

PMID36636604
PMCPMC9831717
OpenAlexW4313456675

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.